APOA1 and metabolic syndrome: The production of ApoA-I regulating factors, including the modulation of the concentration of ApoA-I mRNA in tissues, are important factors determining the concentration of HDL-C in plasma and may contribute to relative resistance to hypercholesterolemia, atherosclerosis, and MetS.